{"about":{"non_affiliation":"Code with Papers and Syntology are not affiliated with, endorsed by, or sponsored by Papers with Code, Meta, or the pwc-archive mirror.","site":"https://codewithpapers.app","licence":"CC BY-SA 4.0","licence_url":"https://creativecommons.org/licenses/by-sa/4.0/legalcode","attribution":"https://codewithpapers.app/attribution","modified":"archive material modified by Syntology; see the attribution page","syntology":{"site":"https://syntology.ai","developers":"https://syntology.ai/developers","mcp":{"server":"https://syntology.ai/mcp","transport":"streamable-http","server_card":"https://syntology.ai/.well-known/mcp/server-card.json","auth":{"type":"trial token, no account","trial_token":"https://syntology.ai/api/oauth/trial/token","method":"POST","docs":"https://syntology.ai/developers"}},"have":"https://syntology.ai/api/graph/have?x=<method, arXiv id or title> (free, answers coverage only)","paper_base":"https://syntology.ai/paper/","atlas_base":"https://app.syntology.ai/?focus="},"machine_readable":[{"url":"https://codewithpapers.app/llms.txt","what":"the machine catalog: every machine-readable file, counted"},{"url":"https://codewithpapers.app/index/manifest.json","what":"paper-to-code index by arXiv id, with Syntology's counts"},{"url":"https://codewithpapers.app/search/manifest.json","what":"site search index (titles, authors) and its files"},{"url":"https://codewithpapers.app/download","what":"bulk files: Syntology's layer, described there"},{"url":"https://codewithpapers.app/build_manifest.json","what":"the build record: inputs, counts, exclusions, probes"}]},"url":"/paper/asgard-a-single-cell-guided-pipeline-to-aid","title":"ASGARD: A Single-cell Guided pipeline to Aid Repurposing of Drugs","arxiv_id":"2109.06377","date":"2021-09-14","proceeding":null,"authors":["Bing He","Yao Xiao","Haodong Liang","Qianhui Huang","Yuheng Du","Yijun Li","David Garmire","Duxin Sun","Lana X. Garmire"],"abstract":"Intercellular heterogeneity is a major obstacle to successful precision medicine. Single-cell RNA sequencing (scRNA-seq) technology has enabled in-depth analysis of intercellular heterogeneity in various diseases. However, its full potential for precision medicine has yet to be reached. Towards this, we propose a new drug recommendation system called: A Single-cell Guided Pipeline to Aid Repurposing of Drugs (ASGARD). ASGARD defines a novel drug score predicting drugs by considering all cell clusters to address the intercellular heterogeneity within each patient. We tested ASGARD on multiple diseases, including breast cancer, acute lymphoblastic leukemia, and coronavirus disease 2019 (COVID-19). On single-drug therapy, ASGARD shows significantly better average accuracy (AUC of 0.92) compared to two other bulk-cell-based drug repurposing methods (AUC of 0.80 and 0.76). It is also considerably better (AUC of 0.82) than other cell cluster level predicting methods (AUC of 0.67 and 0.55). In addition, ASGARD is also validated by the drug response prediction method TRANSACT with Triple-Negative-Breast-Cancer patient samples. Many top-ranked drugs are either approved by FDA or in clinical trials treating corresponding diseases. In silico cell-type specific drop-out experiments using triple-negative breast cancers show the importance of T cells in the tumor microenvironment in affecting drug predictions. In conclusion, ASGARD is a promising drug repurposing recommendation tool guided by single-cell RNA-seq for personalized medicine. ASGARD is free for educational use at https://github.com/lanagarmire/ASGARD.","url_abs":"https://arxiv.org/abs/2109.06377v4","url_pdf":"https://arxiv.org/pdf/2109.06377v4.pdf","source":{"archive":"pwc-archive (Hugging Face), CC BY-SA 4.0","snapshot":"2025-07-28","licence_url":"https://creativecommons.org/licenses/by-sa/4.0/legalcode","row_kind":"abstracts"},"code_links":[{"paper_slug":"asgard-a-single-cell-guided-pipeline-to-aid","repo_url":"https://github.com/lanagarmire/asgard","is_official":1,"mentioned_in_paper":1,"mentioned_in_github":0,"framework":"none","reach":null}],"tasks":[{"task_slug":"drug-response-prediction","task_name":"Drug Response Prediction"}],"methods":[],"datasets_introduced":[],"methods_introduced":[],"results":[],"syntology":{"syntology_url":null,"atlas_url":null,"mcp":null,"developers":"https://syntology.ai/developers","held":null,"reason":"arxiv_id_not_in_atlas","checked_against":{"atlas_ids":549449,"atlas_ids_sha256":"afd72399dafd9906e9062927f70655952385a3d75488558e1f0484e950ab09b7","read_at":"2026-10-05T01:46:21Z"},"by_repo":[{"repo":"lanagarmire/asgard","kind":"official","samples":0,"ran":0,"instrument":0,"unverified":0}],"by_repo_is":"one row per repository in the archive's code links, Syntology's graph links or the samples; samples 0 means no sample is linked to this paper, a statement about Syntology's coverage, not about the repository: with harvested_for_other_papers present, Syntology harvested the repository for that many other papers, and without it, Syntology harvested nothing from it; placed_by_identical_code counts samples whose link records no repository, placed here because identical code was harvested from this repository for another paper; ran counts executions on a synthesized input and instrument counts failures of Syntology's instrument, not of the code"},"code_links_note":null,"arxiv_metadata":null,"syntology_extracted_results":null,"record_sha256":"e8d53883efbec66ea0ebf591dd311645efb525a9966309c964cace320441172b","record_changed_at":"2026-09-28","record_changed_at_basis":"first_hashed"}